Comparison of nifekalant and lidocaine for the treatment of shock-refractory ventricular fibrillation

Circulation Journal

Volumn 70, Issue 4, 2006, Pages 442-446

  Tahara, Yoshio ^a   Kimura, Kazuo ^a   Kosuge, Masami ^a   Ebina, Toshiaki ^a   Sumita, Shinichi ^a   Hibi, Kiyoshi ^a   Toyama, Hideshi ^a   Kosuge, Takayuki ^a   Moriwaki, Yoshihiro ^a   Suzuki, Noriyuki ^a   Sugiyama, Mitsugi ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Antiarrhythmic agents; Cardiac arrest; Cardiopulmonary resuscitation; Emergency care; Ventricular fibrillation

Indexed keywords

LIDOCAINE; NIFEKALANT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; ELECTRIC SHOCK; FEMALE; HEART ARREST; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RESUSCITATION; SURVIVAL RATE;

AGED; ANTI-ARRHYTHMIA AGENTS; CARDIOPULMONARY RESUSCITATION; EPINEPHRINE; FEMALE; HEART ARREST; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PYRIMIDINONES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 33645357292     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.442     Document Type: Article

References (27)

1. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104: 2158-2163.
2. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98: 2334-2351.
3. SOS-KANTO Committee. Incidence of ventricular fibrillation in patients with out-of-hospital cardiac arrest in Japan. Circ J 2005; 69: 1157-1162.
4. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: International consensus on science. Circulation 2000; 102(Suppl I): I-142-I-157.
5. The Public Access Defibrillation Trial Investigators. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med 2004; 351: 637-646.
6. Bunch TJ, White RD, Gersh BJ, Meverden RA, Hodge DO, Ballman KV, et al. Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med 2003; 348: 2626-2633.
7. Still I, Nichol G, Wells G, Maio VD, Nesbitt L, Blackburn J, et al. Health-related quality of life is better for cardiac arrest survivors who received citizen cardiopulmonary resuscitation. Circulation 2003; 108: 1939-1944.
8. Capucci A, Aschieri D, Piepoli MF, Bardy GH, Iconomu E, Arvedi M. Tripling survival from sudden cardiac arrest via early defibrillation without traditional education in cardiopulmonary resuscitation. Circulation 2002; 106: 1065-1070.
9. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002; 346: 884-890.
10. Nakaya H, Uemura H. Electropharmacology of nifekalant, a new class III antiarrhythmic drug. Cardiovasc Drug Rev 1998; 16: 133-144.
11. Yoshioka K, Amino M, Morita S, Nakagawa Y, Usui K, Sugimoto A, et al. Can nifekalant hydrochloride be used as a first-line drug for cardiopulmonary arrest (CPA)? Circ J 2006; 70: 21-27.
12. Katoh T, Mitamura H, Matsuda N, Takano T, Ogawa S, Kasanuki H. Emergency treatment with nifekalant, a novel class III anti-arrhythmic agent, for life-threatening refractory ventricular tachyarrhythmias. Circ J 2005; 69: 1237-1243.
13. Cummins RO, Eisenberg MS, Hallstrom AP, Litwin PE. Survival of out-of-hospital cardiac arrest with early initiation of cardiopulmonary resuscitation. Am J Emerg Med 1985; 3: 114-119.
14. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999; 341: 871-878.
15. Sugiyama A, Satoh Y, Hashimoto K. Acute electropharmacological effects of intravenously administered amiodarone assessed in the invivo canine model. Jpn J Pharmacol 2001; 87: 74-82.
16. Kondoh K, Hashimoto H, Nishiyama H, Umemura K, Ozaki T, Uematsu T, et al. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model. J Cardiovasc Pharmacol 1994; 23: 674-680.
17. Sen L, Cui G, Sakaguchi Y, Singh BH. Electrophysiological effects of MS-551, a new class III agent: Comparison with dl-sotalol in dogs. J Pharmacol Exp Ther 1998; 285: 687-694.
18. Takenaka K, Yasuda S, Miyazaki S, Kurita T, Sutani Y, Morii I, et al. Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction. Jpn Circ J 2001; 65: 60-62.
19. Murakawa Y, Yamashita T, Kanese Y, Omata M. Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation? J Am Coll Cardiol 1997; 29: 688-692.
20. Murakawa Y, Yamashita T, Kanese Y, Omata M. Do the effects of antiarrhythmic drugs on defibrillation efficacy vary among different shock waveforms? Pacing Clin Electrophysiol 1998; 21: 1901-1908.
21. Murakawa Y, Yamashita T, Kanese Y, Omata M. Effect of a class III antiarrhythmic drug on the configuration of dose response curve for defibrillation. Pacing Clin Electrophysiol 1999; 22: 479-486.
22. Wilde AA, Janse MJ. Electrophysiological effects of ATP sensitive potassium channel modulation: Implications for arrhythmogenesis. Cardiovasc Res 1994; 28: 16-24.
23. Cummins RO, Eisenberg MS, Hallstrom AP, Litwin PE. Survival of out-of-hospital cardiac arrest with early initiation of cardiopulmonary resuscitation. Am J Emerg Med 1985; 3: 114-119.
24. Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP. Predicting survival from out-of-hospital cardiac arrest: A graphic model. Ann Emerg Med 1993; 22: 1652-1658.
25. Cummins RO, Ornato JP, Thies WH, Pepe PE. Improving survival from sudden cardiac arrest: The "chain of survival" concept: A statement for heart professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association. Circulation 1991; 83: 1832-1847.
26. Nagao K, Hayashi N, Kanmatsuse K, Arima K, Ohtsuki J, Kikushima K, et al. Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital. J Am Coll Cardiol 2000; 36: 776-783.
27. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346: 549-556.